International Journal of Alzheimer's Disease (Jan 2011)

Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain

  • Elin S. Blom,
  • Yijing Wang,
  • Lena Skoglund,
  • Anita C. Hansson,
  • Massimo Ubaldi,
  • Anbarasu Lourdusamy,
  • Wolfgang H. Sommer,
  • Matthew Mielke,
  • Bradley T. Hyman,
  • Markus Heilig,
  • Lars Lannfelt,
  • Lars N. G. Nilsson,
  • Martin Ingelsson

DOI
https://doi.org/10.4061/2011/936580
Journal volume & issue
Vol. 2011

Abstract

Read online

Several components in the Wnt pathway, including β-catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P<.05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt pathway regulation may signify synaptic rearrangement or neurogenesis.